SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    T-K Clarke, R C Crist, A Ang, L M Ambrose-Lanci, F W Lohoff, A J Saxon, W Ling, M P Hillhouse, R D Bruce, G Woody, W H Berrettini, Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females, The Pharmacogenomics Journal, 2014, 14, 3, 303

    CrossRef

  2. 2
    Avijit Podder, Nidhi Jatana, N. Latha, Human Dopamine Receptors Interaction Network (DRIN): A systems biology perspective on topology, stability and functionality of the network, Journal of Theoretical Biology, 2014, 357, 169

    CrossRef

  3. 3
    Richard C Crist, Toni-Kim Clarke, Alfonso Ang, Lisa M Ambrose-Lanci, Falk W Lohoff, Andrew J Saxon, Walter Ling, Maureen P Hillhouse, R Douglas Bruce, George Woody, Wade H Berrettini, An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans, Neuropsychopharmacology, 2013, 38, 10, 2003

    CrossRef

  4. 4
    R.C. Crist, L.M. Ambrose-Lanci, M. Vaswani, T.K. Clarke, A. Zeng, C. Yuan, T.N. Ferraro, H. Hakonarson, K.M. Kampman, C.A. Dackis, H.M. Pettinati, C.P. O’Brien, D.W. Oslin, G.A. Doyle, F.W. Lohoff, W.H. Berrettini, Case–control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations, Drug and Alcohol Dependence, 2013, 127, 1-3, 122

    CrossRef

  5. 5
    Toni-Kim Clarke, Richard C. Crist, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O’Brien, David W. Oslin, Thomas N. Ferraro, Falk W. Lohoff, Wade H. Berrettini, Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine, Neuroscience Letters, 2013, 542, 71

    CrossRef

  6. 6
    B. Cupic, J. Stefulj, E. Zapletal, A. Matosic, T. Bordukalo-Niksic, L. Cicin-Sain, J. Gabrilovac, Opioid system genes in alcoholism: A case–control study in Croatian population, Neuropeptides, 2013, 47, 5, 315

    CrossRef

  7. 7
    Richard C. Crist, Wade H. Berrettini, Pharmacogenetics of OPRM1, Pharmacology Biochemistry and Behavior, 2013,

    CrossRef

  8. 8
    Igor Bazov, Olga Kononenko, Hiroyuki Watanabe, Vesna Kuntić, Daniil Sarkisyan, Malik M. Taqi, Muhammad Z. Hussain, Fred Nyberg, Tatjana Yakovleva, Georgy Bakalkin, The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction, Addiction Biology, 2013, 18, 1
  9. 9
    D. Proudnikov, M. Randesi, O. Levran, H. Crystal, M. Dorn, J. Ott, A. Ho, M. J. Kreek, Association of Polymorphisms of the Mu Opioid Receptor Gene with the Severity of HIV Infection and Response to HIV Treatment, Journal of Infectious Diseases, 2012, 205, 11, 1745

    CrossRef

  10. 10
    Lara A. Ray, Christina S. Barr, Julie A. Blendy, David Oslin, David Goldman, Raymond F. Anton, The Role of the Asn40Asp Polymorphism of the Mu Opioid Receptor Gene (OPRM1) on Alcoholism Etiology and Treatment: A Critical Review, Alcoholism: Clinical and Experimental Research, 2012, 36, 3
  11. 11
    Jorge Sepulveda, Pharmacogenomics of Alcohol and Drugs of Abuse, 2012,

    CrossRef

  12. 12
    Janine D. Flory, Carolyn L. Pytte, Yasmin Hurd, Robert E. Ferrell, Stephen B. Manuck, Alcohol dependence, disinhibited behavior and variation in the prodynorphin gene, Biological Psychology, 2011, 88, 1, 51

    CrossRef

  13. 13
    Paula J. Bice, Dongbing Lai, Lili Zhang, Tatiana Foroud, Fine Mapping Quantitative Trait Loci that Influence Alcohol Preference Behavior in the High and Low Alcohol Preferring (HAP and LAP) Mice, Behavior Genetics, 2011, 41, 4, 565

    CrossRef

  14. You have free access to this content14
    Mitsuru Kimura, Susumu Higuchi, Genetics of alcohol dependence, Psychiatry and Clinical Neurosciences, 2011, 65, 3
  15. 15
    Kenneth S. Kendler, Gursharan Kalsi, Peter A. Holmans, Alan R. Sanders, Steven H. Aggen, Danielle M. Dick, Fazil Aliev, Jianxin Shi, Douglas F. Levinson, Pablo V. Gejman, Genomewide Association Analysis of Symptoms of Alcohol Dependence in the Molecular Genetics of Schizophrenia (MGS2) Control Sample, Alcoholism: Clinical and Experimental Research, 2011, 35, 5
  16. 16
    Shinya Kasai, Kazutaka Ikeda, Pharmacogenomics of the human µ-opioid receptor, Pharmacogenomics, 2011, 12, 9, 1305

    CrossRef

  17. 17
    Stephen D. Mague, Julie A. Blendy, OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models, Drug and Alcohol Dependence, 2010, 108, 3, 172

    CrossRef

  18. 18
    Narelle K. Hansell, Arpana Agrawal, John B. Whitfield, Katherine I. Morley, Scott D. Gordon, Penelope A. Lind, Michele L. Pergadia, Grant W. Montgomery, Pamela A. F. Madden, Richard D. Todd, Andrew C. Heath, Nicholas G. Martin, Can We Identify Genes For Alcohol Consumption In Samples Ascertained For Heterogeneous Purposes?, Alcoholism: Clinical and Experimental Research, 2009, 33, 4
  19. 19
    Shinya Kasai, Masakazu Hayashida, Ichiro Sora, Kazutaka Ikeda, Candidate gene polymorphisms predicting individual sensitivity to opioids, Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 377, 4-6, 269

    CrossRef

  20. 20
    Ildiko Racz, Britta Schürmann, Anna Karpushova, Martin Reuter, Sven Cichon, Christian Montag, Robert Fürst, Christian Schütz, Petra E. Franke, Jana Strohmaier, Thomas F. Wienker, Lars Terenius, Urban Ösby, Agneta Gunnar, Wolfgang Maier, Andras Bilkei-Gorzó, Markus Nöthen, Andreas Zimmer, The Opioid Peptides Enkephalin and β-Endorphin in Alcohol Dependence, Biological Psychiatry, 2008, 64, 11, 989

    CrossRef